Using Existing Drugs as Leads for Broad Spectrum Anthelmintics Targeting Protein Kinases

• Christina M. Taylor,

  Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• John Martin,

  Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Ramakrishna U. Rao,

  Affiliation Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Kerrie Powell,

  Affiliation SCYNEXIS, Inc., Research Triangle Park, North Carolina, United States of America

  ⨯
• Sahar Abubucker,

  Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Makedonka Mitreva

  * E-mail: mmitreva@genome.wustl.edu

  Affiliations The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯